Stanford University


Showing 3,741-3,760 of 7,899 Results

  • Sara Marie Krzyzaniak

    Sara Marie Krzyzaniak

    Clinical Professor, Emergency Medicine

    BioSara M. Krzyzaniak, MD, is a Clinical Professor of Emergency Medicine at Stanford University School of Medicine and the Program Director for the Stanford Emergency Medicine Residency. She has held progressive leadership roles in undergraduate and graduate medical education since completing her Emergency Medicine residency training at Denver Health Medical Center, with prior faculty appointments at the University of Illinois College of Medicine before joining Stanford.

    Dr. Krzyzaniak’s scholarly work focuses on medical education, with particular emphasis on gender equity, assessment and feedback, faculty development, and leadership training within academic medicine. She has authored more than forty peer-reviewed publications, multiple book chapters, and several volumes within the Education Theory Made Practical series. Her academic contributions also include more than one hundred invited national and international presentations.

    At Stanford, Dr. Krzyzaniak teaches and mentors across all stages of medical education and holds administrative, curricular, and clinical teaching responsibilities. She serves on numerous institutional and national committees, contributes as an editorial board member and ad hoc reviewer for journals in both emergency medicine and medical education, and maintains an active portfolio of professional service. Her leadership and educational contributions have been recognized through multiple national awards for teaching excellence, mentorship, and program leadership.

    Dr. Krzyzaniak’s work is characterized by a sustained commitment to advancing the training of future emergency physicians, strengthening the academic mission of emergency medicine, and contributing to the broader scholarship of medical education.

  • Kristina Kudelko

    Kristina Kudelko

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program

  • Ellen Kuhl

    Ellen Kuhl

    Catherine Holman Johnson Director of Stanford Bio-X, Walter B Reinhold Professor in the School of Engineering, Professor of Mechanical Engineering and, by courtesy, of Bioengineering

    Current Research and Scholarly Interestscomputaitonal simulation of brain development, cortical folding, computational simulation of cardiac disease, heart failure, left ventricular remodeling, electrophysiology, excitation-contraction coupling, computer-guided surgical planning, patient-specific simulation

  • Michael Kuiken

    Michael Kuiken

    Distinguished Visiting Fellow, HOOVER RESEARCH

    BioMike Kuiken is a Distinguished Visiting Fellow at Stanford University's Hoover Institution and serves as Vice Chair of the U.S.-China Economic and Security Review Commission.

    In the private sector, Mike is the Managing Member of Silver Valley Strategies, where he advises founders, CEOs, and investors on geopolitical and government strategies. He is an advisor to the Special Competitive Studies Project (SCSP) and a member of Anthropic's National Security and Public Sector Advisory Council. He serves on the boards of the National Defense Industrial Association and the Planetary Science Institute. His writing has appeared in the Financial Times, Newsweek, and the Boston Globe.

    Mike previously served as Senate Majority Leader Schumer's National Security Advisor. He was a 'Gang of Eight' staffer for over seven years. He architected the legislative strategy to pass the CHIPS and Science Act and played a key role in establishing the Senate's Artificial Intelligence Insight Forums. Prior to the Leader's office, Mike spent over a decade on the Senate Armed Services Committee, a career that began with the late Senator Carl Levin.

    His work has spanned the most consequential challenges of the post-9/11 era—from the wars in Afghanistan and Iraq to today's strategic competition with China. He has shaped U.S. responses to the Arab Spring, Russia's invasion of Ukraine, economic statecraft, and strategic cyber competition, working on the ground in over 85 countries to bring a frontline perspective to national policy.

    Mike earned his B.A. in Political Science and Economics from Calvin University and his M.A. in International Commerce and Policy from George Mason University.

  • Andre Kumar MD, MEd

    Andre Kumar MD, MEd

    Clinical Professor, Medicine

    BioDr. Andre Kumar is a Clinical Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.

    Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.

    Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of free educational content for POCUS, including videos for the Stanford Medicine 25 series, New England Journal of Medicine, and JAMA, which have amassed over 1,000,000 views worldwide.

    Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program and Co-Director of Clinical Reasoning at Stanford School of Medicine. He previously served as President for the Society of Hospital Medicine Bay Area and Director of the Rathmann Medical Education Fellowship.

    List of publications: https://bit.ly/3eop95i

    ClinicalTrials.Gov registration:
    https://bit.ly/2TizOmD
    https://bit.ly/2zeNBjJ

    Media:
    https://shorturl.at/rNU46
    https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
    https://bit.ly/33MZa0O
    https://bit.ly/3t8HE2u
    https://wb.md/2zfjY1N

  • Anshul Kundaje

    Anshul Kundaje

    Associate Professor of Genetics and of Computer Science

    Current Research and Scholarly InterestsWe develop statistical and machine learning frameworks to model gene regulation and decipher the genetic and molecular basis of disease

  • Christian Kunder

    Christian Kunder

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.

    I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.

    I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies.